Zoetis (ZTS)
(Delayed Data from NYSE)
$179.66 USD
+0.28 (0.16%)
Updated Jul 24, 2024 04:00 PM ET
Pre-Market: $179.66 0.00 (0.00%) 9:20 AM ET
4-Sell of 5 4
D Value A Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZTS 179.66 +0.28(0.16%)
Will ZTS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ZTS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZTS
USNA vs. ZTS: Which Stock Is the Better Value Option?
USNA or ZTS: Which Is the Better Value Stock Right Now?
ZTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Theravance Bio (TBPH) Down 6.1% Since Last Earnings Report: Can It Rebound?
Why Is Catalent (CTLT) Up 0.4% Since Last Earnings Report?
Why Is Esperion Therapeutics (ESPR) Up 14.2% Since Last Earnings Report?
Other News for ZTS
Deep Dive Into Zoetis Stock: Analyst Perspectives (4 Ratings)
Zoetis initiated with bullish view at BTIG, here's why
Andvari Associates Q2 2024 Letter
Buy Rating Affirmed for Zoetis Amidst Favorable Market Dynamics and Strong Growth Potential
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years